Boston Scientific (NYSE:BSX) reported quarterly earnings results on February 04, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.80, beating the consensus estimate of $0.78 by $0.02 per share. Revenue came in at $5.3B, beating the estimate of $5.3B.
Boston Scientific's stock moved following the earnings release. The stock currently trades at $76.50 with a market capitalization of $136.0B.


